Informações:
Falhas:
ID
36695
Descrição
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02432950
Link
https://clinicaltrials.gov/show/NCT02432950
Palavras-chave
Versões (1)
- 02/06/2019 02/06/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
2 de junho de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Obesity NCT02432950
Eligibility Obesity NCT02432950
- StudyEvent: Eligibility
Similar models
Eligibility Obesity NCT02432950
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Early-Stage Breast Carcinoma TNM Breast tumor staging
Item
patients with early-stage breast cancer (stage i-iii)
boolean
C2986665 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,2])
Chemotherapy | Chemotherapy Absent | Adjuvant Chemotherapy Completed
Item
patients who have or have not undergone chemotherapy are both eligible; if the patient has undergone chemotherapy she must have completed adjuvant chemotherapy for >= 3 months and =< 5 years prior to study enrollment
boolean
C0392920 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
Postmenopausal state | Natural menopause | Menopause Chemotherapy Induced | Follicle stimulating hormone level Postmenopausal state | Estradiol level Postmenopausal state
Item
postmenopausal women defined by either: natural menopause with at least one year since last menses, or chemotherapy-induced menopause with at least one year since last menses and follicle-stimulating hormone (fsh) and estradiol levels within the postmenopausal range
boolean
C0232970 (UMLS CUI [1])
C0856856 (UMLS CUI [2])
C0025320 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0205263 (UMLS CUI [3,3])
C0428406 (UMLS CUI [4,1])
C0232970 (UMLS CUI [4,2])
C1443016 (UMLS CUI [5,1])
C0232970 (UMLS CUI [5,2])
C0856856 (UMLS CUI [2])
C0025320 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0205263 (UMLS CUI [3,3])
C0428406 (UMLS CUI [4,1])
C0232970 (UMLS CUI [4,2])
C1443016 (UMLS CUI [5,1])
C0232970 (UMLS CUI [5,2])
Body mass index
Item
body mass index (bmi) of 25-33 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Hormone Therapy Adjuvant
Item
patients undergoing current adjuvant endocrine therapy are eligible
boolean
C0279025 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
C1522673 (UMLS CUI [1,2])
Adherence Program Pancreatic Nutritional | Protocol Compliance
Item
patients must be willing to adhere to the pnp intervention and the entire 6-month study
boolean
C1510802 (UMLS CUI [1,1])
C3484370 (UMLS CUI [1,2])
C0030274 (UMLS CUI [1,3])
C1521739 (UMLS CUI [1,4])
C0525058 (UMLS CUI [2])
C3484370 (UMLS CUI [1,2])
C0030274 (UMLS CUI [1,3])
C1521739 (UMLS CUI [1,4])
C0525058 (UMLS CUI [2])
Informed Consent
Item
all patients must have the ability and the willingness to sign a written informed consent
boolean
C0021430 (UMLS CUI [1])
Diabetic
Item
patients who are diabetic
boolean
C0241863 (UMLS CUI [1])
Body mass index Ineligible
Item
patients whose bmi falls outside the eligible range (< 25 kg/m^2 or > 33 kg/m^2)
boolean
C1305855 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C1512714 (UMLS CUI [1,2])
Breast Carcinoma TNM Breast tumor staging
Item
patients with stage iv breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,2])